Non-Invasive Ventilation in Pulmonary Edema

Sponsor
Ospedale S. Giovanni Bosco (Other)
Overall Status
Completed
CT.gov ID
NCT00453947
Collaborator
(none)
60
1
34
1.8

Study Details

Study Description

Brief Summary

This randomized controlled trial is primarily aimed at assessing the rate of acute myocardial infarction with the two noninvasive ventilatory techniques, non-invasive intermittent positive pressure ventilation and non-invasive continuous positive airway pressure.

Condition or Disease Intervention/Treatment Phase
  • Device: CPAP and Non Invasive Ventilation
Phase 4

Detailed Description

Objective: To determine whether the application of non-invasive intermittent positive pressure ventilation (n-IPPV) increases the incidence of acute myocardial infarction (AMI) in patients with acute respiratory failure (ARF) secondary to acute cardiogenic pulmonary edema (ACPE), as opposed to non-invasive continuous positive airway pressure (n-CPAP).

Background Both n-CPAP or n-IPPV are used to treat ACPE complicated by ARF. Two previous studies, however, report an increased rate of AMI associated with the use of n-IPPV.

Methods: Fifty-two patients with severe ARF consequent to ACPE were randomized to receive n-CPAP (n=27) or n-IPPV (n=25), both associated with standard medical therapy. Cardiac markers, electrocardiogram and clinical-physiological parameters were monitored at study entry, after 30 and 60 minutes, and every 6 hours for the first two days.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Non Invasive Positive Airway Pressure And Risk Of Myocardial Infarction In Acute Cardiogenic Pulmonary Edema: Continuous Positive Airway Pressure Vs Non Invasive Positive Pressure Ventilation
Study Start Date :
Jul 1, 2002
Actual Study Completion Date :
May 1, 2005

Outcome Measures

Primary Outcome Measures

  1. The rate of Acute Myocardial Infarction []

Secondary Outcome Measures

  1. Rate of endotracheal intubation []

  2. Mortality []

  3. Time of recovery (i.e. duration of ventilatory assistance) []

  4. High Dependency Unit and hospital length of stay []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • rapid onset of the symptoms

  • severe dyspnoea at rest

  • respiratory rate > 30 breaths per minute

  • use of accessory respiratory muscles

  • oxygen saturation (SpO2) inferior to 90% with an inspiratory oxygen fraction of 60% via a Venturi mask

  • radiological findings of ACPE

Exclusion Criteria:
  • acute ischemic heart disease (myocardial infarction, chest pain, ST elevation)

  • hemodynamic instability (i.e. systolic blood pressure < 90 with dopamine or dobutamine infusion ≥ 5 mcgr/Kg/min) or life-threatening arrhythmias

  • need for immediate endotracheal intubation (respiratory arrest, bradypnea or gasping)

  • inability to protect the airways

  • impaired sensorium (i.e. unconsciousness or agitation)

  • inability to clear secretions

  • respiratory tract infection

  • recent oesophageal/gastric surgery

  • gastrointestinal bleeding

  • facial deformities

  • hematological malignancy or cancer with an Eastern Cooperative Oncology Group performance status ≥ 2

  • chronic respiratory failure necessitating long-term oxygen therapy

  • diagnosis of myocardial infarction, pulmonary embolism, pneumonia, exacerbation of chronic obstructive pulmonary disease, pneumothorax in the previous 3 months

  • denial or refusal of intubation

  • claustrophobia

  • inclusion in other research protocols

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ospedale San Giovanni Bosco Medicina d'Urgenza Torino Italy 10154

Sponsors and Collaborators

  • Ospedale S. Giovanni Bosco

Investigators

  • Principal Investigator: Giovanni Ferrari, MD, Ospedale San Giovanni Bosco ASL4 Torino Italy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00453947
Other Study ID Numbers:
  • gbosco2
First Posted:
Mar 29, 2007
Last Update Posted:
Mar 29, 2007
Last Verified:
Mar 1, 2007
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 29, 2007